Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

The ITGB6 gene is important for tissue repair and hair growth, and mutations can lead to enamel defects and other health issues.

Oral contraceptives may cause hair loss in women.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

The patient's hair loss was likely not caused by beta blockers but possibly by stress or other factors.

Reducing iron levels didn't improve heart health or metabolism in women with certain ovarian issues.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Oral contraceptives may cause significant hair loss in women.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Certain hormone treatments can improve acne and related conditions in women.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

New treatments for PCOS focus on managing symptoms and improving fertility.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Hair loss led to the diagnosis of Cushing's disease in a patient, showing that hair loss can be a sign of hormonal disorders.